Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin- producing cells in the ...

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...

But the immune system may get confused for many reasons. In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case ...

Vertex halts VX-264 diabetes cell therapy due to poor efficacy in Phase 1/2 study, but continues Phase 3 trial of zimislecel ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several updates on the Company’s type 1 diabetes (T1D) ...

A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a ...

Johns Hopkins engineers are developing treatments for Type 1 diabetes that don't rely on daily insulin injections or wearing ...

Mouse study reveals beneficial bacteria play crucial role in helping insulin-producing cells multiply. Exposure to ...

During the trial, scientists from City of Hope ® will assess if people with early type 1 diabetes can protect and preserve ...